Global Therapeutic Protein Market Outlook

The global therapeutic protein market is estimated to grow at a CAGR of 9.6% during the forecast period. Therapeutic proteins are the developed proteins in the laboratory intended for pharmaceutical use. Recombinant DNA technology makes it easy to make proteins in particular host cells such as bacteria, yeast, or mammalian cells under optimum conditions. The host for the production chosen depends on the protein required. Mammalian cells are the most favored host cell as their posttranslational modifications like glycosylation and sialylation significantly impact the proteins pharmacokinetics and protein efficiency. Therapeutic proteins help in the personalized medicine concept. They make it easy for the individualized treatment by associating with the specifically targeted therapeutic procedure by recompensing the deficiency of the deficient protein.

Top Driver: Introduction &Adoption of New Plasma-Derived Therapies and rising in the Prevalence of Chronic Disorders
The major factors that propel the growth of the global protein therapeutics market are the introduction & adoption of new plasma-derived therapies, rising in the prevalence of chronic & life-threatening diseases, and growing awareness among the populace concerning the high efficiency of protein therapeutics. On the other hand, the high cost of protein therapies and complex reimbursement scenarios hinder the market growth. Conversely, introduction in novel indications for known protein therapeutics and untapped emerging markets are expected to create lucrative opportunities for the manufacturers in this industry.

Cancer Segment is Estimated to Witness Significant Growth During the Forecast Period
The global therapeutic protein market has been segmented into cancer, infectious disease, hemophilia, and others based on indications. Among these, the cancer segment is estimated to holds the largest market share and is expected to continue the trend during the forecast period. The growth is attributed to increasing incidences of cancer across the world. Based on therapeutic protein type, the market is segmented into monoclonal antibodies, erythropoietin, insulin, interferon, and others. On the end-user, the market is segmented into pharmaceutical companies, healthcare service providers, research organizations, and others.

Emerging Market Players in the Untapped Region and Rising R&D Activities to Benefit Asia Pacific Market
Asia-Pacific is expected to be the fastest-growing regional market. The growth is attributed to the emerging market players in the untapped region, rising R&D activities in the protein therapeutics segment, growing focus of government toward vaccination to prevent various diseases, and massive target population. For instance, the Japanese government has been offering free hepatitis testing since 2002 for all citizens aged between 40 and 70 years of age as part of routine health check-ups. The rising geriatric population is one of the significant factors propelling market growth in the region.

Players to Focus on Research and Development
The global therapeutics market is estimated to stay fragmented during the forecast period owing to the possible new entrants. The major market players operating in the market include Abbott Laboratories, Amgen Inc., Baxter International Inc., Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co., Inc., Novo Nordisk A/S, Pfizer Inc., and Sanofi. Other players (profiles not included in the report) in the value chain analysis include Biogen, Inc., CSL Behring, and Genentech, Inc.
Baxter International Inc.: In September 2020, Baxter International Inc., a global leader in clinical nutrition received the U.S. Food and Drug Administration (FDA) approval of new formulations of Clinimix Injections and Clinimix E Injections. The Clinimix formulations contain up to 80 g/L of amino acids, the highest protein in any multi-chamber bag available in the U.S., making it easier to reach patient protein targets while delivering less fluid and dextrose than provided by existing formulations.

Scope of the Report
By Indication
Cancer
Hemophilia
Infectious disease
Others

By Therapeutic Protein
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Others

By End-Users
Pharmaceutical companies
Healthcare service providers
Research Organizations
Academic Research Institutes

By Region

North America
Europe
Asia Pacific
Rest Of World

Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Therapeutic Protein Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Therapeutic Protein Market -Industry Snapshots
6.1 Overview
6.1.1 Global Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Therapeutic Protein Market Analysis, by Indication
7.1 Overview
7.2 Key Findings for Therapeutic Protein Market- By Indication
7.2.1 Therapeutic Protein Market- Cancer
7.2.2 Therapeutic Protein Market- Hemophilia
7.2.3 Therapeutic Protein Market- Infectious disease
7.2.4 Therapeutic Protein Market- Others

Chapter 8 Global Therapeutic Protein Market Analysis, by Therapeutic Protein
8.1 Overview
8.2 Key Findings for Therapeutic Protein Market- By Therapeutic Protein
8.2.1 Therapeutic Protein Market- Monoclonal Antibodies
8.2.2 Therapeutic Protein Market- Interferon
8.2.3 Therapeutic Protein Market- Erythropoietin
8.2.4 Therapeutic Protein Market- Insulin
8.2.5 Therapeutic Protein Market- Others

Chapter 9 Global Therapeutic Protein Market Analysis, by End User
9.1 Overview
9.2 Key Findings for Therapeutic Protein Market- By End User
9.2.1 Therapeutic Protein Market- Pharmaceutical companies
9.2.2 Therapeutic Protein Market- Healthcare service providers
9.2.3 Therapeutic Protein Market- Research Organizations
9.2.4 Therapeutic Protein Market- Academic Research Institutes

Chapter 10 Therapeutic Protein Market Analysis by Region
10.1 Key Findings for Therapeutic Protein Market- By region
10.2 Overview
10.2.1 Global Therapeutic Protein Market Analysis, By Indication, 2019 - 2028
10.2.2 Global Therapeutic Protein Market Analysis, By Therapeutic Protein, 2019 - 2028
10.2.3 Global Therapeutic Protein Market Analysis, By End User, 2019 - 2028
10.3 Therapeutic Protein Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Indication
10.3.6 North America Market, By Therapeutic Protein
10.3.7 North America Market, By End User
10.4 Therapeutic Protein Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Indication
10.4.8 Europe Market, By Therapeutic Protein
10.4.9 Europe market by, End User
10.5 Therapeutic Protein Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Indication
10.5.7 Asia Pacific Market, By Therapeutic Protein
10.5.8 Asia Pacific Market, By End User
10.6 Therapeutic Protein Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 South America
10.6.4 Rest Of World
10.6.5 South America, Middle East and Africa Market, By Indication
10.6.6 South America, Middle East and Africa Market, By Therapeutic Protein
10.6.7 South America, Middle East and Africa Market, By End User

Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments

Chapter 12 Company Profiles- Snapshot
12.1 Abbott Laboratories
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Amgen Inc.
12.3 Baxter International Inc.
12.4 Eli Lilly and Company
12.5 F. Hoffmann-La Roche Ltd.
12.6 Johnson & Johnson
12.7 Merck & Co., Inc.
12.8 Novo Nordisk A/S
12.9 Pfizer Inc.
12.10 Sanofi
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 13 Appendix

List Of Tables

TABLE 1 Therapeutic Protein market by Indication 1, 2019 - 2028 (USD Million)
TABLE 2 Therapeutic Protein market by Indication 2, 2019 - 2028 (USD Million)
TABLE 3 Therapeutic Protein market by Indication 3, 2019 - 2028 (USD Million)
TABLE 4 Therapeutic Protein market by Indication 4, 2019 - 2028 (USD Million)
TABLE 5 Therapeutic Protein market by Therapeutic Protein 1, 2019 - 2028 (USD Million)
TABLE 6 Therapeutic Protein market by Therapeutic Protein 2, 2019 - 2028 (USD Million)
TABLE 7 Therapeutic Protein market by Therapeutic Protein 3, 2019 - 2028 (USD Million)
TABLE 8 Therapeutic Protein market by Therapeutic Protein 4, 2019 - 2028 (USD Million)
TABLE 9 Therapeutic Protein market by Therapeutic Protein 5, 2019 - 2028 (USD Million)
TABLE 10 Therapeutic Protein market by End User 1, 2019 - 2028 (USD Million)
TABLE 11 Therapeutic Protein market by End User 2, 2019 - 2028 (USD Million)
TABLE 12 Therapeutic Protein market by End User 3, 2019 - 2028 (USD Million)
TABLE 13 Therapeutic Protein market by End User 4, 2019 - 2028 (USD Million)
TABLE 14 Global Therapeutic Protein Market Value, By Indication, 2019 - 2028 (US$ Bn)
TABLE 15 Global Therapeutic Protein Market Value, By Therapeutic Protein, 2019 - 2028 (US$ Bn)
TABLE 16 Global Therapeutic Protein Market Value, By End User, 2019 - 2028 (US$ Bn)
TABLE 17 Therapeutic Protein Market Analysis by North America (USD Million), 2019 - 2028
TABLE 18 U.S. Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 19 U.S. Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 20 U.S. Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 21 U.S. Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 22 Canada Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 23 Canada Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 24 Canada Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 25 Canada Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 26 Mexico Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 27 Mexico Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 28 Mexico Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 29 Mexico Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 30 Therapeutic Protein Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 31 Germany Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 32 Germany Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 33 Germany Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 34 Germany Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 35 United Kingdom Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 36 United Kingdom Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 37 United Kingdom Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 38 United Kingdom Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 39 France Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 40 France Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 41 France Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 42 France Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 43 Italy Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 44 Italy Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 45 Italy Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 46 Italy Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 47 Rest Of Europe Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 48 Rest Of Europe Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 49 Rest Of Europe Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 50 Rest of Europe Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 51 Therapeutic Protein Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 52 China Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 53 China Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 54 China Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 55 China Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 56 Japan Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 57 Japan Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 58 Japan Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 59 Japan Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 60 India Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 61 India Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 62 India Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 63 India Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 64 Rest of APAC Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 65 Rest of APAC Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 66 Rest of APAC Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 67 Rest of APAC Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 68 Therapeutic Protein Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 69 Middle East & Africa (MEA) Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 70 Middle East & Africa (MEA) Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 71 Middle East & Africa (MEA) Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 72 Middle East & Africa (MEA) Market, By End User, 2019 - 2028 (USD Million)
TABLE 73 South America Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 74 South America Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 75 South America Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 76 South America Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)
TABLE 77 Rest Of World Therapeutic Protein Market, 2019 - 2028 (USD Million)
TABLE 78 Rest Of World Therapeutic Protein Market, By Indication, 2019 - 2028 (USD Million)
TABLE 79 Rest Of World Therapeutic Protein Market, By Therapeutic Protein, 2019 - 2028 (USD Million)
TABLE 80 Rest Of World Therapeutic Protein Market, By End User, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Therapeutic Protein: Market Segmentation
FIG. 2 Global Therapeutic Protein Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Therapeutic Protein Market Value Contribution, By Indication, 2019 & 2026 (%)
FIG. 9 Global Therapeutic Protein Market Value Contribution, By Therapeutic Protein, 2019 & 2026 (%)
FIG. 10 Global Therapeutic Protein Market Value Contribution, By End User, 2019 & 2026 (%)
FIG. 11 Global Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Therapeutic Protein Market Segment 1 North America
FIG. 14 Therapeutic Protein Market Segment 2 North America
FIG. 15 Therapeutic Protein Market Segment 3 North America
FIG. 16 Therapeutic Protein U.S. outlook, 2019 & 2026
FIG. 17 Therapeutic Protein Canada outlook, 2019 & 2026
FIG. 18 Therapeutic Protein Mexico outlook, 2019 & 2026
FIG. 19 Europe Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Therapeutic Protein Market Segment 1 Europe
FIG. 21 Therapeutic Protein Market Segment 2 Europe
FIG. 22 Therapeutic Protein Market Segment 3 Europe
FIG. 23 Therapeutic Protein Germany outlook, 2019 & 2026
FIG. 24 Therapeutic Protein United Kingdom outlook, 2019 & 2026
FIG. 25 Therapeutic Protein France outlook, 2019 & 2026
FIG. 26 Therapeutic Protein Italy outlook, 2019 & 2026
FIG. 27 Therapeutic Protein Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Therapeutic Protein Market Segment 1 Asia Pacific
FIG. 30 Therapeutic Protein Market Segment 2 Asia Pacific
FIG. 31 Therapeutic Protein Market Segment 2 Asia Pacific
FIG. 32 Therapeutic Protein China outlook, 2019 & 2026
FIG. 33 Therapeutic Protein Japan outlook, 2019 & 2026
FIG. 34 Therapeutic Protein India outlook, 2019 & 2026
FIG. 35 Therapeutic Protein Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Therapeutic Protein Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Therapeutic Protein Market Segment 1 Rest Of World
FIG. 38 Therapeutic Protein Market Segment 2 Rest Of World
FIG. 39 Therapeutic Protein Market Segment 3 Rest Of World
FIG. 40 Therapeutic Protein Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Therapeutic Protein South America outlook, 2019 & 2026
FIG. 42 Therapeutic Protein Rest Of World outlook, 2019 & 2026

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available